Evidence mapPaperPMID 41317869Full record

Observational studyEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2026

Understanding Glycemia in the Post Discharge Period Through Blinded Continuous Glucose Monitoring.

Rahul Patel, Mollie Y O'Connor, Amy Sabean, Annabelle Ashley, Hui Zheng, Joyce Yan, Barbara A Steiner, Nillani Anandakugan, Melissa Calverley, Rachel Bartholomew and 5 more

Abstract readObservational Study
In one paragraph

Observational study in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rahul PatelDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Mollie Y O'ConnorDivision of Endocrinology, New York University Langone Health, New York, New York.
Amy SabeanDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Annabelle AshleyDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Hui ZhengBiostatics Center, Massachusetts General Hospital, Boston, Massachusetts.
Joyce YanBiostatics Center, Massachusetts General Hospital, Boston, Massachusetts.
Barbara A SteinerDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Nillani AnandakuganDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Melissa CalverleyDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Rachel BartholomewDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Evelyn GreauxDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Mary LarkinDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.
Steven J RussellDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts; Beta Bionics Inc, Concord, Massachusetts.
Melissa S PutmanDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: msputman@mgh.harvard.edu.
Kristen L FlintDiabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts.

Funding

TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
Clinical studies of a bionic pancreas for automated glucose management in cystic fibrosis-related diabetes mellitusR01DK119699 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PUTMAN, MELISSA SUSAN · 2019 to 2024
$3.4M
NIDDK NIH HHS R01 DK119699NIDDK NIH HHS T32 DK007028
6 · The paper itself

Abstract

objectiveTransitions of care at hospital discharge are critical time periods for people with diabetes, but little is known about glycemia in the immediate postdischarge period.

methodsIn this observational study, participants wore blinded Dexcom G6 Pro CGM during hospital admission on nonintensive care floors and then continued wearing blinded continuous glucose monitoring (CGM) for up to 10 days posthospital discharge. Clinical data were extracted from the electronic medical record. Percent time in range 70-180 mg/dl (TIR), above range, and below range from the inpatient and postdischarge periods were calculated. The percentage of participants achieving TIR ≥50% and ≥70%, incidence of hypoglycemia after discharge, change in inpatient and postdischarge CGM metrics, and predictors of postdischarge glycemia were determined.

resultsA total of 24 adults (mean age 65.7 ± 13.6 years, 37.5% female) wore CGM after discharge with mean TIR 43.9 ± 33.2%, mean time above range 55.9 ± 33.3%, and median time below range 0% (0, 0.04). Of these participants, 41.7% had TIR ≥50%, and 29.2% had TIR ≥70%. Glycemia predischarge and postdischarge was similar (postdischarge vs inpatient TIR -3.7 ± 22.5%, P = .4). Of the clinical factors assessed, only inpatient glycemia was associated with achieving postdischarge glycemic targets. CGM detected 13 episodes of hypoglycemia occurring in 6 participants (25%) postdischarge.

conclusionsGlycemia during the postdischarge period is suboptimal and glucose levels in the hospital may be an important predictor of glycemia after hospitalization. CGM may be useful in identifying hypoglycemia after discharge. Further studies are needed to understand the utility of CGM after hospital discharge.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringPatient DischargeAgedContinuous Glucose MonitoringFemaleHumansHypoglycemiaMaleMiddle AgedBlood Glucosecontinuous glucose monitoringhospital dischargehypoglycemia

Identifiers

PMID41317869
PMCPMC12998547

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.